Press Release: Dupixent® (dupilumab) approved by European Commission as first and only targeted medicine for children as young as six months old with severe atopic dermatitis Read more about Press Release: Dupixent® (dupilumab) approved by European Commission as first and only targeted medicine for children as young as six months old with severe atopic dermatitis
Sonaecom, SGPS, S.A. informs on Addendum to the Report of the Board of Directors. Read more about Sonaecom, SGPS, S.A. informs on Addendum to the Report of the Board of Directors.
Schibsted ASA (SCHA/SCHB) - Repurchase of own shares Read more about Schibsted ASA (SCHA/SCHB) - Repurchase of own shares
Grant of share options to primary insiders in NRC Group ASA Read more about Grant of share options to primary insiders in NRC Group ASA
Himalaya Shipping Ltd. (HSHIP) - 2023 Special General Meeting Read more about Himalaya Shipping Ltd. (HSHIP) - 2023 Special General Meeting
Key information relating to the preferential rights issue to be carried out by poLight ASA Read more about Key information relating to the preferential rights issue to be carried out by poLight ASA
poLight ASA: Contemplated underwritten rights issue - notice of extraordinary general meeting Read more about poLight ASA: Contemplated underwritten rights issue - notice of extraordinary general meeting